Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The effect of aspartame on the innate immune ability of Caenorhabditis elegans.

ABSTRACT: Aspartame is a non carbohydrate artificial sweetener widely used in medicine and food. Some scholars believe that aspartame has neurotoxicity, mainly due to the presence of phenylalanine in its metabolites, which can pass through the blood-brain barrier, change the brain amino acid ratio, and interfere with neurotransmitter transmission. However, whether aspartame has an impact on human innate immunity is still unknown. This experiment will use Caenorhabditis elegans as a model to study its effect on innate immunity and provide reliable data support for the safety of aspartame as a sweetener.

ORGANISM(S): Caenorhabditis elegans

PROVIDER: GSE273859 | GEO | 2025/12/31

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Transgenerational transmission of aspartame induced anxiety and changes in glutamate-GABA signaling and gene expression in the amygdala

Project description:We show that daily exposure of mice to aspartame, an artificial sweetener found in over 5,000 diet foods and drinks at doses equivalent to only 15% of the FDA recommended maximum daily intake for humans produces anxiety. The anxiety is alleviated by diazepam, a drug used in the treatment of generalized anxiety disorder. We completed RNA sequencing of the amygdala of male mice that were exposed to aspartame or plain drinking water (control), as this brain region regulates anxiety and fear. The aspartame exposure produces changes in the expression of genes regulating excitation-inhibition balance in the amygdala. The anxiety, its response to diazepam and the changes in amygdala gene expression are not limited to the aspartame-exposed individuals but also appear in up to two generations descending from the aspartame-exposed males. Thus, aspartame’s neurobehavioral effects are not limited to those who consume it but also impact generations of descendants, a finding that highlights the need for a re-evaluation of current policies on artificial sweetener use.

2022-10-12 | GSE210561 | GEO

Cellular stress, inflammation and barrier damage in gut epithelial cells caused by aspartame

Project description:Aspartame has been widely used as a sweetener in foods and beverages since the 1980s. In this study, we aimed to assess the effect of aspartame on gut epithelial cell biology, inflammation, and the epithelial barrier. Aspartame shows cytotoxic effects and epithelial barrier damage as well as proinflammatory cytokine release in gastrointestinal epithelial cells, organoids and organ-on-a-chips at concentrations corresponding to daily used doses in food products. Cellular cytotoxicity was observed in as low as 1.25 mg/ml doses. RNA sequencing analysis revealed that aspartame significantly altered the transcriptome in gut-on-a-chip models, showing upregulation of pathways such as unfolded protein response, activated pro-apoptotic and inflammatory, and downregulation of DNA repair and replication mechanisms pathways. Aspartame exposure upregulated proinflammatory genes, particularly in the TNF signalling pathway, and induced multiple chemokine responses. It activated the NF-κB pathway via oxidative stress, promoting inflammation on NF-κB reporter monocyte cells and causing gut epithelial cell death. Aspartame affected genes involved in tight and adherens junctions, disrupting gut epithelial barrier integrity in a dose-dependent manner in gut-on-a-chip models. Additionally, aspartame suppressed key DNA repair and replication genes involved in double-strand break repair, mismatch repair, and DNA replication. Overall, our findings indicate that at commonly consumed levels, aspartame induces cellular stress, inflammation, and epithelial barrier damage in gastrointestinal epithelial cells. These findings underscore the biological relevance of our results and raise concerns that daily dietary intake of aspartame may pose previously underappreciated risks to gut health.

2026-01-01 | GSE285905 | GEO

The effect of aspartame on the innate immune ability of Caenorhabditis elegans.

Project description:The effect of aspartame on the innate immune ability of Caenorhabditis elegans.

| PRJNA1143501 | ENA

Gut bacterial phenylalanine decarboxylase induces brain phenylethylamine accumulation and neurotoxicity in liver failure

Project description:Gut bacterial,phenylalanine decarboxylase,phenylethylamine,neurotoxicity, liver

| PRJEB66346 | ENA

Defining blood-induced microglia functions in neurodegeneration through multiomic profiling

Project description:Blood protein extravasation through a disrupted blood–brain barrier and innate immune activation are hallmarks of neurological diseases and emerging therapeutic targets. However, how blood proteins polarize innate immune cells remains largely unknown. Here, we established an unbiased blood-innate immunity multiomic and genetic loss-of-function pipeline to define the transcriptome and global phosphoproteome of blood-induced innate immune polarization and its role in microglia neurotoxicity. Blood induced widespread microglial transcriptional changes, including changes involving oxidative stress and neurodegenerative genes. Comparative functional multiomics showed that blood proteins induce distinct receptor-mediated transcriptional programs in microglia and macrophages, such as redox, type 1 interferon and lymphocyte recruitment. Deletion of the blood coagulation factor fibrinogen largely reversed blood-induced microglia neurodegenerative signatures. Genetic elimination of the fibrinogen-binding motif to CD11b in Alzheimer’s disease mice reduced microglial lipid metabolism and neurodegenerative signatures that were shared with autoimmune-driven neuroinflammation in multiple sclerosis mice. Our data provide an interactive resource for investigation of the immunology of blood proteins that could support therapeutic targeting of microglia activation by immune and vascular signals.

2023-06-02 | PXD021230 | Pride

Phenylalanine Impairs Insulin Signaling and Inhibits Glucose Uptake Through Modification of IRβ

Project description:Whether amino acids act on cellular insulin signaling remains unclear, given that increased circulating amino acid levels are associated with the onset of type 2 diabetes (T2D). Here, we report that phenylalanine modifies insulin receptor beta (IRβ) and inactivates insulin signaling and glucose uptake. Mice fed phenylalanine-rich chow or phenylalanine-producing aspartame or overexpressing human phenylalanyl-tRNA synthetase (hFARS) developed insulin resistance and T2D symptoms. Mechanistically, FARS phenylalanylated lysine 1057/1079 of IRβ (F-K1057/1079), inactivating IRβ and preventing insulin from promoting glucose uptake by cells. SIRT1 reversed F-K1057/1079 and counteracted the insulin-inactivating effects of hFARS and phenylalanine. F-K1057/1079 and SIRT1 levels in white blood cells from T2D patients wereare positively and negatively correlated with T2D onset, respectively. Blocking F-K1057/1079 with phenylalaninol sensitizeds insulin signaling and relieveds T2D symptoms in hFARS-transgenic and db/db mice. These findings shed light on the activation of insulin signaling and T2D progression through inhibition of phenylalanylation.

2022-07-22 | PXD035076 | Pride

Expression data from cortical tissue of 5XFAD mice treated with 5B8 antibody or IgG control

Project description:Activation of innate immunity and deposition of blood-derived fibrin in the central nervous system (CNS) occur in autoimmune and neurodegenerative diseases, including multiple sclerosis (MS) and Alzheimer’s disease (AD). However, mechanisms linking blood-brain barrier (BBB) disruption with neurodegeneration are poorly understood, and exploration of fibrin as a therapeutic target has been limited by its beneficial clotting functions. Here we report the generation of monoclonal antibody 5B8 targeted against the cryptic fibrin epitope γ377-395 to selectively inhibit fibrin-induced inflammation. 5B8 suppressed fibrin-induced proinflammatory gene expression, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation, and oxidative stress. In animal models of MS and AD, 5B8 entered the CNS and bound to parenchymal fibrin, and its therapeutic administration reduced innate immune activation and neurodegeneration without interfering with clotting. Thus, fibrin-targeting immunotherapy inhibits autoimmune- and amyloid-driven neurotoxicity and may have clinical benefit without globally suppressing innate immunity or interfering with coagulation in diverse neurological diseases.

2019-02-13 | GSE118920 | GEO

Expression data from fibrin-stimulated macrophages treated with 5B8 antibody or IgG2b control

2019-02-13 | GSE118921 | GEO

Expression data from adult mouse hypothalamus

Project description:Chronic dietary aspartame may impair rodent insulin tolerance and may affect behavior. Previous studies have shown the aspartame effects may be modulated by developmental NMDA receptor antagonism. Present study was designed to assess effects of aspartame and NMDAR antagonism on components of the HPA axis. We used microarray analysis to examine changes in adult rodent hypothalamic gene expression following chronic aspartame exposure and/or developmental NMDA receptor antagonism.

2018-03-11 | GSE100325 | GEO

Expression data from adult mouse adrenal tissue

Project description:Chronic dietary aspartame may impair rodent insulin tolerance and may affect behavior. Previous studies have shown the aspartame effects may be modulated by developmental NMDA receptor antagonism. Present study was designed to assess effects of aspartame and NMDAR antagonism on components of the HPA axis. We used microarray analysis to examine changes in adult rodent adrenal gene expression following chronic aspartame exposure and/or developmental NMDA receptor antagonism.

2018-03-11 | GSE100324 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data